Sage Therapeutics
SAGE
SAGE was delisted on the 30th of July, 2025.
248 hedge funds and large institutions have $4.65B invested in Sage Therapeutics in 2020 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 74 increasing their positions, 85 reducing their positions, and 33 closing their positions.
55% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 33
43% more capital invested
Capital invested by funds: $3.26B → $4.65B (+$1.39B)
18% more call options, than puts
Call options by funds: $54.8M | Put options by funds: $46.6M
8% more funds holding
Funds holding: 230 → 248 (+18)
0.12% more ownership
Funds ownership: 103.25% → 103.37% (+0.12%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
13% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 85
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$298M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$32.5M |
| 3 |
PA
Perceptive Advisors
New York
|
+$32.4M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$26.5M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$22.1M |
Top Sellers
SAGE Hedge Fund Activity: Q4 2020 in Review
248 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q4 2020, worth a combined $4.65B — up 43% from $3.26B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new SAGE positions and 33 closed out — a net gain of 18 holders — while 74 added to existing stakes and 85 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $298M. The largest seller was Great Point Partners, cutting an estimated $111M.
- 248 institutional investors held Sage Therapeutics (SAGE) as of Q4 2020, up from 230 in Q3 2020.
- Funds reported $4.65B of Sage Therapeutics stock for Q4 2020, up 43% quarter-over-quarter.
- 51 funds opened new Sage Therapeutics positions in Q4 2020 and 33 closed out, a net change of +18 holders.
- The largest Sage Therapeutics buyer in Q4 2020 was Wellington Management Group, an estimated $298M added.
- The largest Sage Therapeutics seller in Q4 2020 was Great Point Partners, an estimated $111M sold.
Based on aggregated 13F filings for Q4 2020.